LIF and breast carcinoma: Previous work has demonstrated that LIF can induce STAT3 signaling in breast cancer cells [73,106], and STAT3 has been previously identified as a pro-dormancy factor in ER+ breast cancer cells [107] and prevents colonization of the bone by disseminated tumor cells [73].